Home
Dashboard
About ONE
Curated content
Guide
Companies
Investors
More organizations
Job board
Transactions
Stats & Insights
Matching tool
Companies
Vtesse Pharma
Team
Team
Save
Vtesse Pharma
Developed VTS-270 to treat patients with Niemann-Pick Disease Type C.
Launch date
2014
Employees
2-10 people
Market cap
-
Enterprise valuation
€62—93m
(Dealroom.co estimates Jul 2016.)
Gaithersburg Maryland (HQ)
http://www.vtessepharma.com
https://www.linkedin.com/company/vtesse-inc-
B2B
manufacturing
health
biotechnology
hard tech
biotechnology
biotech and pharma
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Authorizing premium user...